维普中文期刊产品整合服务
25篇 您的检索式:作者名="Bedard PL"
    题名 作者 年代 出处 被引量
1Luminal-B breast cancer and novel therapeutic targets显示文摘Tran B Bedard PL 2011Breast Cancer Res2011,13,6:1
2International Guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy 显示文摘Cardoso F Bedard PL Winer EP 2009J Natl Cancer Inst2009,101,:1
3A phase i study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors(PHL-078/CTEP 8575)显示文摘Richter S Bedard PL Chen EX 2014Invest New Drugs2014,32,2:1
4Stemming resistance to HER-2 targeted therapy显示文摘Bedard PL Gardoso F Piccart-Gebhart MJ 2009J Mammary Gland Biol Neoplasia2009,14,1:1
5Cardiac toxicity with anti-HER-2 therapies:what have we learned so far?显示文摘de Azambuja E Bedard PL Suter T 2009Target Oncol2009,4,:1
6The genetic basis for cancer treatment decisions显示文摘Dancey JE Bedard PL Onetto N 0,,03:1
7A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints显示文摘Fumagalli D Bedard PL Nahleh Z 2012Lancet Oncol2012,13,6:1
8Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer显示文摘Bedard PL Di Leo A Piccart-Gebhart MJ 2010Nat Rev Clin Oncol2010,7,1:1
9Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome显示文摘Mazouni C Bedard PL Nahleh Z 2007J Clin Oncol2007,25,19:1
10LuminaI-B breast cancer and novel therapeutic targets显示文摘Tran B Bedard PL 2011Breast Cancer Pes2011,15,6:1
11Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?显示文摘de Azambuja E Bedard PL Suter T 2009Target Oncol2009,4,2:1
12International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy 显示文摘Cardoso F Bedard PL Winer EP 2009J Natl Cancer Inst2009,101,:1
13Tnmour heterogeneity in the clinic显示文摘Bedard PL Hansen AR Ratain M J 2013Nature2013,501,7467:1
14International guidelines for management of metastatic breast cancer:combination vs sequential single-agent chemotherapy显示文摘Cardoso F Bedard PL Winer EP 2009J Natl Cancer Inst2009,101,:1
15Feasibility of real time next generation sequencing of cancer genes linked to drug response:results from a clinical trial显示文摘Tran B Brown AM Bedard PL 2013Int J Cancer2013,132,7:1
16Brain metastases in HER2 - positive breast cancer: the evolving role of Lapatinib 显示文摘Tomasello G Bedard PL de Azambuja E ct al 2010Crit Rev Oncol Hemato12010,75,2:1
17International guidelines for management of metastatic breast cancer: combination vs sequential single - agent chemotherapy显示文摘Cardoso F Bedard PL Wirier EP 2009J Natl Cancer Inst2009,101,17:1
18Tumour hetero- geneity in the clinic显示文摘Bedard PL Hansen AR Ratain MJ 2013Nature2013,501,7467:1
19International guidelines for management of metastatic breast cancer:combination vs sequential single-agent chemotherapy显示文摘Cardoso F Bedard PL Winer EP 2009J Natl Cancer Inst2009,101,17:1
20Cardiac toxicity with anti-HER-2 therapies: what have we learned so far? 显示文摘De Azambuja E Bedard PL Suter T 2009Target Oncol2009,4,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费